Insights On Trial Design
-
Decision-Making For The Adoption Of A 'Bring Your Own Device' Strategy
4/18/2023
Set explicit expectations about what "bring your own device" strategies should be, the associated risks, and propose structured help to support successful decision-making processes and implementation.
-
Insights: Global Patient Views And Engagement In Clinical Trials
4/15/2024
Enhancing the patient journey within clinical trials begins with engaging participants to understand their needs and preferences, ensuring they enroll and remain committed throughout the study.
-
Predictors Of Severe CRS In Longitudinal CAR T-Cell Clinical Trial Data
9/15/2022
Find out how laboratory tests were analyzed with repeated measurements to identify differences in trends that persist across a variety of study designs, sponsors, and indications.
-
Alliance Bolsters Patient Engagement And Data Insights
9/19/2023
Learn how the Metastatic Breast Cancer Alliance’s desire for richer participant information and heightened patient engagement led them to create MBC Connect™.
-
Altasciences Has You Covered From Coast To Coast
1/30/2023
With your success in mind, we designed an integrated early phase drug development offering with eight locations, to get you from lead candidate selection to clinical proof of concept, and beyond.
-
Understanding Clinical Trial Patient Attrition
11/21/2023
Knowing why patients may choose to drop out of a study, such as adverse events, compliance, or external factors, can help sponsors and researchers create a strategy to keep them more engaged.
-
Rare Disease Clinical Trials: Modern Design And Supply Chain
10/12/2023
Gain insight from several contributing experts for overcoming unique obstacles in rare disease research and learn how to better develop strategies.
-
You Need Patients, Not Patience.
9/1/2023
Elligo Health Research® is the ultimate patient provider, giving you immediate access to known, diverse patients so you can quickly get your product to the people who desperately need it.
-
Removing Financial Toxicity From Oncology Clinical Trials Through Patient Reimbursement Programs
9/30/2022
Learn what sites, CROs, and patient advocacy groups are doing to make clinical trials accessible to the most at-risk patients, and the solutions that can maximize diverse clinical trial enrollment.
-
FDORA And The Diversity Action Plan Requirement – Are You Prepared?
10/29/2023
The U.S. Congress recently acted to enhance diversity in clinical trials, necessitating clinical trial sponsors for most drug and device studies to submit a Diversity Action Plan. Revisit the path that brought the industry here.